Project Details
Description
SBIR PHASE I: GENETICALLY ENGINEERED BCG AS A MICROBE-BASED PLATFORM FOR VACCINATION AGAINST COVID-19
| Status | Finished |
|---|---|
| Effective start/end date | 09/1/20 → 08/31/22 |
Funding
- National Science Foundation: $85,000.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.